2-Year Results of the AUTAX (Austrian Multivessel TAXUS-Stent) Registry. Beyond the SYNTAX (Synergy Between Percutaneous Coronary Intervention With TAXUS and Cardiac Surgery) Study

JACC: Cardiovascular Interventions

Volumn 2, Issue 8, 2009, Pages 718-727

  Gyöngyösi, Mariann ^a   Christ, Günter ^a   Lang, Irene ^a   Kreiner, Gerhard ^a   Sochor, Heinz ^a   Probst, Peter ^a   Neunteufl, Thomas ^a   Badr Eslam, Rosa ^a   Winkler, Susanne ^a   Nyolczas, Noemi ^a   Posa, Aniko ^a   Leisch, Franz ^b   Karnik, Ronald ^c   Siostrzonek, Peter ^d   Harb, Stefan ^e   Heigert, Matthias ^f   Zenker, Gerald ^g   Benzer, Werner ^h   Bonner, Gerhard ⁱ   Kaider, Alexandra ^a   Glogar, Dietmar ^a   more..

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b KEPLER UNIVERSITY HOSPITAL   (Austria)

^c Hospital Rudolfstiftung Vienna   (Austria)

^d Krankenhaus der Barmherzigen Schwestern Wien Betriebsgesellschaft   (Austria)

^e UNIVERSITY HOSPITAL GRAZ   (Austria)

^f St Johannes Spital   (Austria)

^g GENERAL HOSPITAL KLAGENFURT   (Austria)

^h Academic Hospital   (Austria)

ⁱ Confraternität Privatklinik Josefstadt ^*  (Austria)

Author keywords

catheterization; coronary disease; revascularization; stents; SYNTAX score

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL;

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; ADULT; AGE DISTRIBUTION; ANGIOCARDIOGRAPHY; ARTICLE; AUSTRIA; CEREBROVASCULAR DISEASE; CLINICAL TRIAL; CORONARY ARTERY DISEASE; CORONARY ARTERY RECANALIZATION; CORONARY STENT; DISEASE SEVERITY; DRUG ELUTING STENT; FEMALE; HUMAN; IMPLANT REGISTRY; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; OUTCOME ASSESSMENT; PATIENT SAFETY; PATIENT SELECTION; PRIORITY JOURNAL; RESTENOSIS; RISK FACTOR; STENT THROMBOSIS; TREATMENT INDICATION;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; AUSTRIA; CORONARY ANGIOGRAPHY; CORONARY ARTERY BYPASS; CORONARY ARTERY DISEASE; CORONARY RESTENOSIS; DRUG-ELUTING STENTS; FEMALE; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; ODDS RATIO; PLATELET AGGREGATION INHIBITORS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; PROSTHESIS DESIGN; REGISTRIES; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; STROKE; THROMBOSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 68749092139     PISSN: 19368798     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcin.2009.05.019     Document Type: Article

References (25)

1. Hoffman S.N., Tenbrook J.A., Wolf M.P., et al. A meta-analysis of randomized controlled trials comparing coronary artery bypass graft with percutaneous transluminal coronary angioplasty: one- to eight-year outcomes. J Am Coll Cardiol 41 (2003) 1293-1304
2. The SoS Investigators. Coronary artery bypass surgery versus percutaneous coronary intervention with stent implantation in patients with multivessel coronary artery disease (the Stent or Surgery trial): a randomised trial. Lancet 360 (2002) 965-970
3. Rodriguez A., Bernardi V., Navia J., et al. Argentine randomized study: coronary angioplasty with stenting versus coronary bypass surgery in patients with multiple-vessel disease (ERACI II): 30-day and one-year follow-up results. J Am Coll Cardiol 37 (2001) 51-58
4. Serruys P.W., Unger F., Sousa J.E., et al. Comparison of coronary-artery bypass surgery and stenting for the treatment of multivessel disease. N Engl J Med 344 (2001) 1117-1124
5. Legrand V.M.G., Serruys P.W., Unger F., et al., Arterial Revascularization Therapy Study (ARTS) Investigators. Three-year outcome after coronary stenting versus bypass surgery for the treatment of multivessel disease. Circulation 109 (2004) 1114-1120
6. Orlic D., Bonizzoni E., Stankovic G., et al. Treatment of multivessel coronary artery disease with sirolimus-eluting stent implantation: immediate and mid-term results. Circulation 109 (2004) 1114-1120
7. Stone G.W., Ellis S.G., Cox D.A., et al. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 350 (2004) 221-231
8. Yang J.H., Gwon H.C., Cho S.J., et al. Comparison of coronary artery bypass grafting with drug-eluting stent implantation for the treatment of multivessel coronary artery disease. Ann Thorac Surg 85 (2008) 65-70
9. Hannan E.L., Wu C., Walford G., et al. Drug-eluting stents vs. coronary-artery bypass grafting in multivessel coronary disease. N Engl J Med 358 (2008) 331-341
10. Berger P.B., Alderman E.L., Nadel A., and Schaff H.V. Frequency of early occlusion and stenosis in the left internal mammary artery among patients undergoing CABG through a median sternotomy on conventional bypass: benchmark for the minimally invasive direct coronary artery bypass. Circulation 100 (1999) 2353-2358
11. DeCanniere D., Jansens J.L., Goldschmidt-Clermont P., Barvais L., Decroly P., and Stoupel E. Combination of minimally invasive coronary bypass and percutaneous transluminal coronary angioplasty in the treatment of double-vessel coronary disease: two-year follow-up of a new hybrid procedure compared with "on-pump" double bypass grafting. Am Heart J 142 (2001) 563-570
12. Kappetein A.P., Dawkins K.D., Mohr F.W., et al. Current percutaneous coronary intervention and coronary artery bypass grafting practices for three-vessel and left main coronary artery disease. Insights from the SYNTAX run-in phase. Eur J Cardiothorac Surg (2006) 29486-91
13. Desai N.D. Pitfalls assessing the role of drug-eluting stents in multivessel coronary disease. Ann Thorac Surg 85 (2008) 25-27
14. Serruys P.W., Morice M.C., Kappetein A.P., et al., SYNTAX Investigators. Percutaneous coronary intervention versus coronary artery bypass grafting for severe coronary artery disease. N Engl J Med 360 (2009) 961-972
15. Hao H., Gabbiani G., Camenzind E., Bacchetta M., Virmani R., and Bochaton-Piallat M.L. Phenotypic modulation of intima and media smooth muscle cells in fatal cases of coronary artery lesions. Atheroscler Thromb Vasc Biol 26 (2006) 326-332
16. Sianos G., Morel M.A., Kappetein A.P., et al. The SYNTAX score: an angiographic tool grading the complexity of coronary artery disease. EuroIntervention 1 (2005) 219-227
17. Laskey W.K., Yancy C.W., and Maisel W.H. Thrombosis in coronary drug-eluting stents: report from the meeting of the Circulatory System Medical Devices Advisory Panel of the Food and Drug Administration Center for Devices and Radiologic Health, December 7-8, 2006. Circulation 115 (2007) 2352-2357
18. Maree A.O., Mieres J., Berrocal D., et al. Late loss of early benefit from drug-eluting stents when compared with bare-metal stents and coronary artery bypass surgery: 3 years follow-up of the ERACI III registry. Eur Heart J 28 (2007) 2118-2125
19. Javaid A., Steinberg D.H., Buch A.N., et al. Outcomes of coronary artery bypass grafting versus percutaneous coronary intervention with drug-eluting stents for patients with multivessel coronary artery disease. Circulation 116 (2007) I200-I206
20. Detter C., Reichenspurner H., Boehm D.H., et al. Minimally invasive direct coronary artery bypass grafting (MIDCAB) and off-pump coronary artery bypass grafting (OPCAB): two techniques for beating heart surgery. Heart Surg Forum 5 (2002) 157-162
21. Serruys P.W., Ong A.T.L., Morice M.-C., et al. Arterial revascularisation therapies study, part II: sirolimus-eluting stents for the treatment of patients with multivessel de novo coronary artery lesions. EuroIntervention 1 (2005) 147-156
22. Hannan E.L., Racz M., Holmes D.R., et al. Impact of completeness of percutaneous coronary intervention revascularization on long-term outcomes in the stent era. Circulation 113 (2006) 2406-2412
23. Alamanni F., Dainese L., Naliato M., et al. On- and off-pump coronary surgery and perioperative myocardial infarction: an issue between incomplete and extensive revascularization. Eur J Cardiothorac Surg 34 (2008) 118-126
24. Harjai K.J., Orshaw P., Shenoy C., et al. Clinical outcomes following drug-eluting versus bare metal stent implantation for lesion subsets excluded from pivotal clinical trials: findings from the GHOST study (Guthrie Health System Off-Label StenT study). J Interv Cardiol 21 (2008) 315-324
25. Applegate R.J., Sacrinty M.T., Kutcher M.A., et al. "Off-label" stent therapy 2-year comparison of drug-eluting versus bare-metal stents. J Am Coll Cardiol 51 (2008) 607-614